104P AI oncology algorithm-based prioritisation of EGFR inhibitors in case of rare EGFR mutations.

MLA

Tihanyi, D., et al. “104P AI Oncology Algorithm-Based Prioritisation of EGFR Inhibitors in Case of Rare EGFR Mutations.” Annals of Oncology, vol. 30, Nov. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1093/annonc/mdz413.108.

APA

Tihanyi, D., Kispeter, E., Vidermann, M., Doczi, R., Hegedus, C., Filotas, P., Urban, L., & Petak, I. (2019). 104P AI oncology algorithm-based prioritisation of EGFR inhibitors in case of rare EGFR mutations. Annals of Oncology, 30, N.PAG. https://doi.org/10.1093/annonc/mdz413.108

Chicago

Tihanyi, D, E Kispeter, M Vidermann, R Doczi, C Hegedus, P Filotas, L Urban, and I Petak. 2019. “104P AI Oncology Algorithm-Based Prioritisation of EGFR Inhibitors in Case of Rare EGFR Mutations.” Annals of Oncology 30 (November): N.PAG. doi:10.1093/annonc/mdz413.108.